Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.
Acta Pharm Sin B
; 9(2): 421-432, 2019 Mar.
Article
en En
| MEDLINE
| ID: mdl-30972286
ALT, alanine transaminase; AST, aspartate transaminase; AUC, area under the curve; Antitumor efficacy; BUN, blood urea nitrogen; C-6, coumarin-6; CREA, creatinine; DDS, drug delivery system; DMSO, dimethyl sulfoxide; DSPE-PEG2K, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000]; DTT, d,l-dithiothreitol; DTX, docetaxel; Docetaxel; EDCI, N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide hydrochloride; FBS, fetal bovine serum; GSH, glutathione; H2O2, hydrogen peroxide; HOBt, 1-hydroxybenzotriazole monohydrate; HPLC, high-performance liquid chromatography; IC50, half maximal inhibitory concentration; LA, linoleic acid; Linoleic acid; MTT, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; Mono thioether bond; Nanoassemblies; PBS, phosphate buffer saline; PDI, polydispersity index; PTX, paclitaxel; Pharmacokinetics; ROS, reactive oxygen species; SD, standard deviation; TLC, thin layer chromatography
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Idioma:
En
Revista:
Acta Pharm Sin B
Año:
2019
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Países Bajos